Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Background It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States. Study Design Cross-sectional and ecologic. Setting & Participants White (n = 16,410) and bl...
Gespeichert in:
Veröffentlicht in: | American journal of kidney diseases 2013-03, Vol.61 (3), p.395-403 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 403 |
---|---|
container_issue | 3 |
container_start_page | 395 |
container_title | American journal of kidney diseases |
container_volume | 61 |
creator | Tanner, Rikki M., MPH Gutiérrez, Orlando M., MD, MMSc Judd, Suzanne, PhD McClellan, William, MD, MPH Bowling, C. Barrett, MD Bradbury, Brian D., DSc Safford, Monika M., MD Cushman, Mary, MD, MSc Warnock, David, MD Muntner, Paul, PhD |
description | Background It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States. Study Design Cross-sectional and ecologic. Setting & Participants White (n = 16,410) and black (n = 11,109) participants from across the continental United States in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Predictor Geographic region, defined by the 18 networks of the US ESRD Network Program. Outcomes & Measurements Albuminuria, defined as albumin-creatinine ratio ≥30 mg/g, and decreased estimated glomerular filtration rate (eGFR), defined as |
doi_str_mv | 10.1053/j.ajkd.2012.10.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659181</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0272638612013960</els_id><sourcerecordid>1288994877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-bef235af11a26f9b86d1b288ba519cb68c1ac325bf5cf9274ac8cdd16e4f577f3</originalsourceid><addsrcrecordid>eNp9kt1uEzEQhVcIREvhBbhAvkEqFwn-2R8vQpWqJA0VlUAbyq3l9Y4bJxs72LuR8kY8Jt4mlMIFV5bOfHNm5DNJ8prgMcEZe78ay9W6GVNMaBTGmPAnySnJKBvlnPGnySmmBR3ljOcnyYsQVhjjkuX58-SEMkp5maanyc85uDsvt0uj0HfpjeyMs8hYNPk8RV897GQLVgGStkGzRTVF11aZ5l6KULcEdGtNBw1adLKD8AFVEPq2C-jKu819vQIZnA1IO48eDRsMK6mMbNHUaA1-8AyD6aLzbg3ovJrNL6vp4l0U-mb_MnmmZRvg1fE9S26vZt8mn0Y3X-bXk8ubkcpS3I1q0JRlUhMiaa7LmucNqSnntcxIqeqcKyIVo1mtM6VLWqRScdU0JIdUZ0Wh2VlycfDd9vUGGgW287IVW2820u-Fk0b8XbFmKe7cTrA8Kwkn0eD8aODdjx5CJzYmKGhbacH1QZC4TVmmvCgiSg-o8i4ED_phDMFiiFisxBCxGCIetBhxbHrzeMGHlt-ZRuDtEZBByVZ7GSMLf7iCFhnJy8h9PHAQv3NnwIugzJBCYzyoTjTO_H-Pi3_aVWusiRPXsIewcr23MShBRKACi8VwjMMtkmjCyhyzXzZE24U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1288994877</pqid></control><display><type>article</type><title>Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Tanner, Rikki M., MPH ; Gutiérrez, Orlando M., MD, MMSc ; Judd, Suzanne, PhD ; McClellan, William, MD, MPH ; Bowling, C. Barrett, MD ; Bradbury, Brian D., DSc ; Safford, Monika M., MD ; Cushman, Mary, MD, MSc ; Warnock, David, MD ; Muntner, Paul, PhD</creator><creatorcontrib>Tanner, Rikki M., MPH ; Gutiérrez, Orlando M., MD, MMSc ; Judd, Suzanne, PhD ; McClellan, William, MD, MPH ; Bowling, C. Barrett, MD ; Bradbury, Brian D., DSc ; Safford, Monika M., MD ; Cushman, Mary, MD, MSc ; Warnock, David, MD ; Muntner, Paul, PhD</creatorcontrib><description>Background It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States. Study Design Cross-sectional and ecologic. Setting & Participants White (n = 16,410) and black (n = 11,109) participants from across the continental United States in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Predictor Geographic region, defined by the 18 networks of the US ESRD Network Program. Outcomes & Measurements Albuminuria, defined as albumin-creatinine ratio ≥30 mg/g, and decreased estimated glomerular filtration rate (eGFR), defined as <60 mL/min/1.73 m2 , were measured in the REGARDS Study. ESRD incidence rates were obtained from the US Renal Data System. Results For whites, the network-specific prevalence of albuminuria ranged from 8.4% (95% CI, 3.3%-13.5%) in Network 15 to 14.8% (95% CI, 8.0%-21.6%) in Network 3, and decreased eGFR ranged from 4.3% (95% CI, 2.0%-6.6%) in Network 4 to 16.7% (95% CI, 12.7%-20.7%) in Network 7. For blacks, the prevalence of albuminuria ranged from 12.1% (95% CI, 8.7%-15.5%) in Network 5 to 26.5% (95% CI, 16.7%-36.3%) in Network 4, and decreased eGFR ranged from 6.7% (95% CI, 5.0%-8.4%) in Network 17/18 to 13.4% (95% CI, 7.8%-19.1%) in Network 12. Spearman correlation coefficients for the prevalence of albuminuria and decreased eGFR with network-specific ESRD incidence rates were 0.49 and 0.24, respectively, for whites and 0.29 and 0.25, respectively, for blacks. Limitations There were few cases of albuminuria and decreased eGFR in some geographic regions. Conclusions In the United States, substantial geographic variations in the prevalence of albuminuria and decreased eGFR exist, but were correlated only modestly with ESRD incidence, suggesting the chronic kidney disease burden may not explain the geographic variation in ESRD incidence.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2012.10.018</identifier><identifier>PMID: 23228944</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; Albuminuria - complications ; Albuminuria - epidemiology ; Albuminuria - physiopathology ; Biological and medical sciences ; Black or African American ; Chronic kidney disease ; Cross-Sectional Studies ; end-stage renal disease ; Female ; geography ; Glomerular Filtration Rate ; Humans ; Incidence ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - physiopathology ; Kidneys ; Male ; Medical sciences ; Middle Aged ; Nephrology ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Renal failure ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - epidemiology ; Renal Insufficiency, Chronic - physiopathology ; Stroke - complications ; Stroke - epidemiology ; United States - epidemiology ; Urinary system involvement in other diseases. Miscellaneous ; White People</subject><ispartof>American journal of kidney diseases, 2013-03, Vol.61 (3), p.395-403</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2013 National Kidney Foundation, Inc.</rights><rights>2014 INIST-CNRS</rights><rights>Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</rights><rights>2012 The National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-bef235af11a26f9b86d1b288ba519cb68c1ac325bf5cf9274ac8cdd16e4f577f3</citedby><cites>FETCH-LOGICAL-c540t-bef235af11a26f9b86d1b288ba519cb68c1ac325bf5cf9274ac8cdd16e4f577f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.ajkd.2012.10.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27275169$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23228944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanner, Rikki M., MPH</creatorcontrib><creatorcontrib>Gutiérrez, Orlando M., MD, MMSc</creatorcontrib><creatorcontrib>Judd, Suzanne, PhD</creatorcontrib><creatorcontrib>McClellan, William, MD, MPH</creatorcontrib><creatorcontrib>Bowling, C. Barrett, MD</creatorcontrib><creatorcontrib>Bradbury, Brian D., DSc</creatorcontrib><creatorcontrib>Safford, Monika M., MD</creatorcontrib><creatorcontrib>Cushman, Mary, MD, MSc</creatorcontrib><creatorcontrib>Warnock, David, MD</creatorcontrib><creatorcontrib>Muntner, Paul, PhD</creatorcontrib><title>Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>Background It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States. Study Design Cross-sectional and ecologic. Setting & Participants White (n = 16,410) and black (n = 11,109) participants from across the continental United States in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Predictor Geographic region, defined by the 18 networks of the US ESRD Network Program. Outcomes & Measurements Albuminuria, defined as albumin-creatinine ratio ≥30 mg/g, and decreased estimated glomerular filtration rate (eGFR), defined as <60 mL/min/1.73 m2 , were measured in the REGARDS Study. ESRD incidence rates were obtained from the US Renal Data System. Results For whites, the network-specific prevalence of albuminuria ranged from 8.4% (95% CI, 3.3%-13.5%) in Network 15 to 14.8% (95% CI, 8.0%-21.6%) in Network 3, and decreased eGFR ranged from 4.3% (95% CI, 2.0%-6.6%) in Network 4 to 16.7% (95% CI, 12.7%-20.7%) in Network 7. For blacks, the prevalence of albuminuria ranged from 12.1% (95% CI, 8.7%-15.5%) in Network 5 to 26.5% (95% CI, 16.7%-36.3%) in Network 4, and decreased eGFR ranged from 6.7% (95% CI, 5.0%-8.4%) in Network 17/18 to 13.4% (95% CI, 7.8%-19.1%) in Network 12. Spearman correlation coefficients for the prevalence of albuminuria and decreased eGFR with network-specific ESRD incidence rates were 0.49 and 0.24, respectively, for whites and 0.29 and 0.25, respectively, for blacks. Limitations There were few cases of albuminuria and decreased eGFR in some geographic regions. Conclusions In the United States, substantial geographic variations in the prevalence of albuminuria and decreased eGFR exist, but were correlated only modestly with ESRD incidence, suggesting the chronic kidney disease burden may not explain the geographic variation in ESRD incidence.</description><subject>Aged</subject><subject>Albuminuria - complications</subject><subject>Albuminuria - epidemiology</subject><subject>Albuminuria - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Black or African American</subject><subject>Chronic kidney disease</subject><subject>Cross-Sectional Studies</subject><subject>end-stage renal disease</subject><subject>Female</subject><subject>geography</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Renal failure</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - epidemiology</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Stroke - complications</subject><subject>Stroke - epidemiology</subject><subject>United States - epidemiology</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><subject>White People</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kt1uEzEQhVcIREvhBbhAvkEqFwn-2R8vQpWqJA0VlUAbyq3l9Y4bJxs72LuR8kY8Jt4mlMIFV5bOfHNm5DNJ8prgMcEZe78ay9W6GVNMaBTGmPAnySnJKBvlnPGnySmmBR3ljOcnyYsQVhjjkuX58-SEMkp5maanyc85uDsvt0uj0HfpjeyMs8hYNPk8RV897GQLVgGStkGzRTVF11aZ5l6KULcEdGtNBw1adLKD8AFVEPq2C-jKu819vQIZnA1IO48eDRsMK6mMbNHUaA1-8AyD6aLzbg3ovJrNL6vp4l0U-mb_MnmmZRvg1fE9S26vZt8mn0Y3X-bXk8ubkcpS3I1q0JRlUhMiaa7LmucNqSnntcxIqeqcKyIVo1mtM6VLWqRScdU0JIdUZ0Wh2VlycfDd9vUGGgW287IVW2820u-Fk0b8XbFmKe7cTrA8Kwkn0eD8aODdjx5CJzYmKGhbacH1QZC4TVmmvCgiSg-o8i4ED_phDMFiiFisxBCxGCIetBhxbHrzeMGHlt-ZRuDtEZBByVZ7GSMLf7iCFhnJy8h9PHAQv3NnwIugzJBCYzyoTjTO_H-Pi3_aVWusiRPXsIewcr23MShBRKACi8VwjMMtkmjCyhyzXzZE24U</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Tanner, Rikki M., MPH</creator><creator>Gutiérrez, Orlando M., MD, MMSc</creator><creator>Judd, Suzanne, PhD</creator><creator>McClellan, William, MD, MPH</creator><creator>Bowling, C. Barrett, MD</creator><creator>Bradbury, Brian D., DSc</creator><creator>Safford, Monika M., MD</creator><creator>Cushman, Mary, MD, MSc</creator><creator>Warnock, David, MD</creator><creator>Muntner, Paul, PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study</title><author>Tanner, Rikki M., MPH ; Gutiérrez, Orlando M., MD, MMSc ; Judd, Suzanne, PhD ; McClellan, William, MD, MPH ; Bowling, C. Barrett, MD ; Bradbury, Brian D., DSc ; Safford, Monika M., MD ; Cushman, Mary, MD, MSc ; Warnock, David, MD ; Muntner, Paul, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-bef235af11a26f9b86d1b288ba519cb68c1ac325bf5cf9274ac8cdd16e4f577f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Albuminuria - complications</topic><topic>Albuminuria - epidemiology</topic><topic>Albuminuria - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Black or African American</topic><topic>Chronic kidney disease</topic><topic>Cross-Sectional Studies</topic><topic>end-stage renal disease</topic><topic>Female</topic><topic>geography</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Renal failure</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - epidemiology</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Stroke - complications</topic><topic>Stroke - epidemiology</topic><topic>United States - epidemiology</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><topic>White People</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanner, Rikki M., MPH</creatorcontrib><creatorcontrib>Gutiérrez, Orlando M., MD, MMSc</creatorcontrib><creatorcontrib>Judd, Suzanne, PhD</creatorcontrib><creatorcontrib>McClellan, William, MD, MPH</creatorcontrib><creatorcontrib>Bowling, C. Barrett, MD</creatorcontrib><creatorcontrib>Bradbury, Brian D., DSc</creatorcontrib><creatorcontrib>Safford, Monika M., MD</creatorcontrib><creatorcontrib>Cushman, Mary, MD, MSc</creatorcontrib><creatorcontrib>Warnock, David, MD</creatorcontrib><creatorcontrib>Muntner, Paul, PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanner, Rikki M., MPH</au><au>Gutiérrez, Orlando M., MD, MMSc</au><au>Judd, Suzanne, PhD</au><au>McClellan, William, MD, MPH</au><au>Bowling, C. Barrett, MD</au><au>Bradbury, Brian D., DSc</au><au>Safford, Monika M., MD</au><au>Cushman, Mary, MD, MSc</au><au>Warnock, David, MD</au><au>Muntner, Paul, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>61</volume><issue>3</issue><spage>395</spage><epage>403</epage><pages>395-403</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>Background It is not known whether geographic differences in the prevalence of chronic kidney disease exist and are associated with end-stage renal disease (ESRD) incidence rates across the United States. Study Design Cross-sectional and ecologic. Setting & Participants White (n = 16,410) and black (n = 11,109) participants from across the continental United States in the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Predictor Geographic region, defined by the 18 networks of the US ESRD Network Program. Outcomes & Measurements Albuminuria, defined as albumin-creatinine ratio ≥30 mg/g, and decreased estimated glomerular filtration rate (eGFR), defined as <60 mL/min/1.73 m2 , were measured in the REGARDS Study. ESRD incidence rates were obtained from the US Renal Data System. Results For whites, the network-specific prevalence of albuminuria ranged from 8.4% (95% CI, 3.3%-13.5%) in Network 15 to 14.8% (95% CI, 8.0%-21.6%) in Network 3, and decreased eGFR ranged from 4.3% (95% CI, 2.0%-6.6%) in Network 4 to 16.7% (95% CI, 12.7%-20.7%) in Network 7. For blacks, the prevalence of albuminuria ranged from 12.1% (95% CI, 8.7%-15.5%) in Network 5 to 26.5% (95% CI, 16.7%-36.3%) in Network 4, and decreased eGFR ranged from 6.7% (95% CI, 5.0%-8.4%) in Network 17/18 to 13.4% (95% CI, 7.8%-19.1%) in Network 12. Spearman correlation coefficients for the prevalence of albuminuria and decreased eGFR with network-specific ESRD incidence rates were 0.49 and 0.24, respectively, for whites and 0.29 and 0.25, respectively, for blacks. Limitations There were few cases of albuminuria and decreased eGFR in some geographic regions. Conclusions In the United States, substantial geographic variations in the prevalence of albuminuria and decreased eGFR exist, but were correlated only modestly with ESRD incidence, suggesting the chronic kidney disease burden may not explain the geographic variation in ESRD incidence.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>23228944</pmid><doi>10.1053/j.ajkd.2012.10.018</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0272-6386 |
ispartof | American journal of kidney diseases, 2013-03, Vol.61 (3), p.395-403 |
issn | 0272-6386 1523-6838 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3659181 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Aged Albuminuria - complications Albuminuria - epidemiology Albuminuria - physiopathology Biological and medical sciences Black or African American Chronic kidney disease Cross-Sectional Studies end-stage renal disease Female geography Glomerular Filtration Rate Humans Incidence Kidney Failure, Chronic - complications Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - physiopathology Kidneys Male Medical sciences Middle Aged Nephrology Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Renal failure Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - epidemiology Renal Insufficiency, Chronic - physiopathology Stroke - complications Stroke - epidemiology United States - epidemiology Urinary system involvement in other diseases. Miscellaneous White People |
title | Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A41%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Geographic%20Variation%20in%20CKD%20Prevalence%20and%20ESRD%20Incidence%20in%20the%20United%20States:%20Results%20From%20the%20Reasons%20for%20Geographic%20and%20Racial%20Differences%20in%20Stroke%20(REGARDS)%20Study&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Tanner,%20Rikki%20M.,%20MPH&rft.date=2013-03-01&rft.volume=61&rft.issue=3&rft.spage=395&rft.epage=403&rft.pages=395-403&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2012.10.018&rft_dat=%3Cproquest_pubme%3E1288994877%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1288994877&rft_id=info:pmid/23228944&rft_els_id=1_s2_0_S0272638612013960&rfr_iscdi=true |